Permutation tests for joinpoint regression with applications to cancer rates.

By Hyune-Ju Kim, M. Fay, E. Feuer, D. Midthune. Statistics in Medicine, 2000

5,863 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Cancer incidence, mortality, and burden in China: a time‐trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020 (2021, methodology): “Joinpoint regressionmodels [22] were used to examine the time trends in ASIRs for selected cancer sites in China, US, and UK for the period 1998-2012.”
Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study (2014, background): “and to determine the best-fit data series.[24] Initially models contained zero joinpoints (i.”
International variation in prostate cancer incidence and mortality rates. (2012, neutral): “The method is described in detail elsewhere [23].”
Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. (2002, background): “Thereafter, incidence in both groups of men declined steadily for several years; recent figures for 1996 through 1998 show levels (2,3).”
Trends in Prescription Drug Use among Adults in the United States from 1999–2012 (2015, neutral): “5-13] 25-<30 1684 939 (57) [52-62] 245 (12) [10-15] 30-<35 1066 1066 (62) [58-66] 212 (17) [15-19] 35-<40 451 284 (68) [60-75] 109 (24) [18-30] ≥40 354 250 (73) [66-78] 117 (29) [24-35] a All paticipants were aged 20 years or older.”